BE1029585B1 - Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire - Google Patents
Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoireInfo
- Publication number
- BE1029585B1 BE1029585B1 BE20216002A BE202106002A BE1029585B1 BE 1029585 B1 BE1029585 B1 BE 1029585B1 BE 20216002 A BE20216002 A BE 20216002A BE 202106002 A BE202106002 A BE 202106002A BE 1029585 B1 BE1029585 B1 BE 1029585B1
- Authority
- BE
- Belgium
- Prior art keywords
- hpbcd
- ciclesonide
- budesonide
- complex
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Composition inhalable comprenant un complexe d'hydroxypropyl-bêta-cyclodextrine (HPBCD) ou d'un dérivé pharmaceutiquement acceptable de celle-ci et de budésonide ou de ciclésonide pour une utilisation dans la prévention topique ou le traitement topique d'une maladie virale respiratoire.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE20216002A BE1029585B1 (fr) | 2021-12-20 | 2021-12-20 | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
PCT/EP2022/086808 WO2023118014A1 (fr) | 2021-12-20 | 2022-12-19 | Compositions inhalables comprenant un complexe de hpbcd et de budésonide ou de ciclésonide pour le traitement ou la prévention d'une maladie virale respiratoire ou d'une inflammation induite par des lipopolysaccharides, en particulier une inflammation induite par lipopolysaccharides associée à une maladie virale respiratoire |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE20216002A BE1029585B1 (fr) | 2021-12-20 | 2021-12-20 | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1029585B1 true BE1029585B1 (fr) | 2023-02-03 |
Family
ID=79686829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE20216002A BE1029585B1 (fr) | 2021-12-20 | 2021-12-20 | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE1029585B1 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1894559A1 (fr) * | 2006-09-01 | 2008-03-05 | PARI Pharma GmbH | Stabilisation de stéroides destinées à être inhalées |
WO2021048322A1 (fr) * | 2019-09-10 | 2021-03-18 | Aquilon Pharmaceuticals | Microparticules de type balle de golf destinées à être utilisées dans le traitement et la prévention de maladies pulmonaires |
US20210346613A1 (en) * | 2020-05-05 | 2021-11-11 | Mahesh Kumar KHAITAN | Controlled delivery device for treating coronavirus infections and methods thereof |
-
2021
- 2021-12-20 BE BE20216002A patent/BE1029585B1/fr active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1894559A1 (fr) * | 2006-09-01 | 2008-03-05 | PARI Pharma GmbH | Stabilisation de stéroides destinées à être inhalées |
WO2021048322A1 (fr) * | 2019-09-10 | 2021-03-18 | Aquilon Pharmaceuticals | Microparticules de type balle de golf destinées à être utilisées dans le traitement et la prévention de maladies pulmonaires |
US20210346613A1 (en) * | 2020-05-05 | 2021-11-11 | Mahesh Kumar KHAITAN | Controlled delivery device for treating coronavirus infections and methods thereof |
Non-Patent Citations (1)
Title |
---|
FLORENCE CARROUEL ET AL: "COVID-19: A Recommendation to Examine the Effect of Mouthrinses with β-Cyclodextrin Combined with Citrox in Preventing Infection and Progression", JOURNAL OF CLINICAL MEDICINE, vol. 9, no. 4, 15 April 2020 (2020-04-15), pages 1126, XP055759526, DOI: 10.3390/jcm9041126 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guggenheimer et al. | Dental management of the (solid) organ transplant patient | |
US8349820B2 (en) | Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido | |
Gaggar et al. | Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis | |
WO2006044916A3 (fr) | Utilisation d'inhibiteurs de la na+/k+-atpase et leurs antagonistes | |
Rozencweig et al. | Overview of phase I trials of 2′, 3′-dideoxyinosine (ddI) conducted on adult patients | |
HUP0100867A2 (hu) | Celecoxib tartalmú gyógyászati készítmények | |
Brown et al. | Mucormycosis of the mandible | |
MA52154B1 (fr) | Composition pharmaceutique pour l'anémie | |
MA30779B1 (fr) | Comprimes pediatriques de capecitabine | |
MA30413B1 (fr) | Nouvelles compositions pharmaceutiques faiblement dosees contenant du nimesulide, leur preparation et utilisation | |
JP2021020945A5 (ja) | エンドセリンb受容体アゴニストを用いた、神経精神疾患を治療するための組成物 | |
RU2007138263A (ru) | Противовоспалительные соединения | |
FitzGerald et al. | Safety of as-needed budesonide-formoterol in mild asthma: data from the two phase III SYGMA studies | |
BE1030002B1 (fr) | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire | |
BE1029585B1 (fr) | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire | |
JP2008533079A5 (fr) | ||
Park et al. | Efficacy and tolerability of GCSB-5 for hand osteoarthritis: a randomized, controlled trial | |
MA54276B1 (fr) | Montélukast destinée au traitement de l'arthrose de la main | |
MA33455B1 (fr) | Otamixaban pour le traitement de patients atteints d'infarctus du myocarde sans élévation du st ages et insuffisants renaux | |
JPH101442A (ja) | 鼻炎用点鼻薬 | |
JPS61106521A (ja) | 血管増殖抑制剤 | |
HUP0201629A2 (hu) | Eletriptánt és ciklodextrinszármazékot tartalmazó gyógyászati komplex, ezt tartalmazó gyógyszerkészítmény, eljárás az előállítására és alkalmazása | |
Cenderello et al. | COVID-19 treatment in the older people: a brief clinical review | |
Al-Mashhadane | Uses and Misuses of Antibiotic in Dental Practice. A review. | |
MA50247B1 (fr) | Compositions aqueuses comprenant de la bilastine et du mométasone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Effective date: 20230203 |